Medtronic(US:MDT) 智通财经网·2025-08-20 15:07Core Insights - Medtronic (MDT.US) shares rose over 4% to $94.04 following the release of its Q1 fiscal year 2026 earnings report, which showed revenue of $8.6 billion, exceeding market expectations of $8.4 billion, driven primarily by growth in the cardiovascular products segment [1] - The company's adjusted earnings per share increased by 2% to $1.26, surpassing the market forecast of $1.23 [1] - Medtronic, along with peers such as Stryker (SYK.US), Boston Scientific (BSX.US), and GE HealthCare Technologies (GEHC.US), revised its tariff cost forecast downwards, now expecting a loss of $185 million compared to the previous estimate of $200 million to $350 million [1] - The company has updated its fiscal year 2026 adjusted earnings per share guidance to a range of $5.60 to $5.66, higher than the prior forecast of $5.50 to $5.60 [1]